Naringin has been demonstrated to reduce glioblastoma cell proliferation by inhibiting the FAK/cyclin D1 pathway, and promoting cell apoptosis by influencing the FAK/bads pathway [138]. The gene discussed is PTK2; the disease is glioblastoma.